Mechanisms of proinflammatory cytokine-induced biphasic NF-κB activation

Molecular Cell

Volumn 12, Issue 5, 2003, Pages 1287-1300

  Schmidt, Christian ^a   Peng, Bailu ^a   Li, Zhongkui ^a   Sclabas, Guido M ^a   Fujioka, Shuichi ^a   Niu, Jiangong ^b   Schmidt Supprian, Marc ^c   Evans, Douglas B ^a   Abbruzzese, James L ^a   Chiao, Paul J ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; PROTEIN; PROTEIN IKK; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM;

EID: 10744225575     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00390-3     Document Type: Article

References (44)

1. Adams D.G., Sachs N.A., Vaillancourt R.R. Phosphorylation of the stress-activated protein kinase, MEKK3, at serine 166. Arch. Biochem. Biophys. 407:2002;103-116.
2. Baeuerle P.A., Baltimore D. A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB. Genes Dev. 3:1989;1689-1698.
3. Beauparlant P., Lin R., Hiscott J. The role of the C-terminal domain of IκBα in protein degradation and stabilization. J. Biol. Chem. 271:1996;10690-10696.
4. Beg A.A., Sha W.C., Bronson R.T., Baltimore D. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:1995;2736-2746. a.
5. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 376:1995;167-170. b.
6. Burke J.R., Wood M.K., Ryseck R.P., Walther S., Meyers C.A. Peptides corresponding to the N and C termini of IκB-α, -β, and -ε as probes of the two catalytic subunits of IκB kinase, IKK-1 and IKK-2. J. Biol. Chem. 274:1999;36146-36152.
7. Cheng Q., Cant C.A., Moll T., Hofer-Warbinek R., Wagner E., Birnstiel M.L., Bach F.H., de Martin R. NF-κB subunit-specific regulation of the IκBα promoter. J. Biol. Chem. 269:1994;13551-13557.
8. Chiao P.J., Miyamoto S., Verma I.M. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA. 91:1994;28-32.
9. Connelly L., Palacios-Callender M., Ameixa C., Moncada S., Hobbs A.J. Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide. J. Immunol. 166:2001;3873-3881.
10. Delhase M., Hayakawa M., Chen Y., Karin M. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science. 284:1999;309-313.
11. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554.
12. Fanger G.R., Widmann C., Porter A.C., Sather S., Johnson G.L., Vaillancourt R.R. 14-3-3 proteins interact with specific MEK kinases. J. Biol. Chem. 273:1998;3476-3483.
13. Fenwick C., Na S.-Y., Voll R.E., Zhong H., Im S.-Y., Lee J.W., Ghosh S. A subclass of Ras proteins that regulate the degradation of IκB. Science. 287:2000;869-873.
14. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell. 109(Suppl):2002;S81-S96.
15. Gilmore T.D., Koedood M., Piffat K.A., White D.W. Rel/NF-κB/ IκB proteins and cancer. Oncogene. 13:1996;1367-1378.
16. Han S.-J., Ko H.-M., Choi J.-H., Seo K.H., Lee H.-S., Choi E.-K., Choi I.-W., Lee H.-K., Im S.-Y. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-κB (NF-κB). J. Biol. Chem. 277:2002;44715-44721.
17. Heilker R., Freuler F., Pulfer R., Di Padova F., Eder J. All three IκB isoforms and most Rel family members are stably associated with the IκB kinase 1/2 complex. Eur. J. Biochem. 259:1999;253-261.
18. Heissmeyer V., Krappmann D., Wulczyn F.G., Scheidereit C. NF-κB p105 is a target of IκB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J. 18:1999;4766-4778.
19. Heissmeyer V., Krappmann D., Hatada E.N., Scheidereit C. Shared pathways of IκB kinase-induced SCF(βTrCP)-mediated ubiquitination and degradation for the NF-κB precursor p105 and IκBα Mol. Cell. Biol. 21:2001;1024-1035.
20. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The IκB-NF-κB signaling module. temporal control and selective gene activation Science. 298:2002;1241-1245.
21. Hu C.D., Chinenov Y., Kerppola T.K. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell. 9:2002;789-798.
22. Karin M., Cao Y., Greten F.R., Li Z.W. NF-κB in cancer. from innocent bystander to major culprit Nat. Rev. Cancer. 2:2002;301-310.
23. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
24. Leitges M., Sanz L., Martin P., Duran A., Braun U., Garcia J.F., Camacho F., Diaz-Meco M.T., Rennert P.D., Moscat J. Targeted disruption of the ζPKC gene results in the impairment of the NF-κB pathway. Mol. Cell. 8:2001;771-780.
25. Li Q., Verma I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2:2002;725-734.
26. Li Q., Lu Q., Hwang J.Y., Buscher D., Lee K.F., Izpisua-Belmonte J.C., Verma I.M. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1999;1322-1328. a.
27. Li Q., Van Antwerp D., Mercurio F., Lee K.F., Verma I.M. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science. 284:1999;321-325. b.
28. Li Q., Estepa G., Memet S., Israël A., Verma I.M. Complete lack of NF-κB activity in IKK1 and IKK2 double-deficient mice. additional defect in neurulation Genes Dev. 14:2000;1729-1733.
29. Luque I., Gelinas C. Distinct domains of IκBα regulate c-Rel in the cytoplasm and in the nucleus. Mol. Cell. Biol. 18:1998;1213-1224.
30. Luque I., Zong W.X., Chen C., Gelinas C. N-terminal determinants of IκBα necessary for the cytoplasmic regulation of c-Rel. Oncogene. 19:2000;1239-1244.
31. Malek S., Huang D.B., Huxford T., Ghosh S., Ghosh G. X-ray crystal structure of an IκBβ x NF-κB p65 homodimer complex. J. Biol. Chem. 278:2003;23094-23100.
32. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2. cytokine-activated IκB kinases essential for NF-κB activation Science. 278:1997;860-866.
33. Regnier C.H., Song H.Y., Gao X., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
34. Schmidt-Supprian M., Bloch W., Courtois G., Addicks K., Israël A., Rajewsky K., Pasparakis M. NEMO/IKKγ-deficient mice model incontinentia pigmenti. Mol. Cell. 5:2000;981-992.
35. Sen R., Baltimore D. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell. 47:1986;921-928.
36. Sun S.C., Ganchi P.A., Ballard D.W., Greene W.C. NF-κB controls expression of inhibitor IκBα evidence for an inducible autoregulatory pathway Science. 259:1993;1912-1915.
37. Takaesu G., Surabhi R.M., Park K.-J., Ninomiya-Tsuji J., Matsumoto K., Gaynor R.B. TAK1 is critical for IκB kinase-mediated activation of the NF-κB pathway. J. Mol. Biol. 326:2003;105-115.
38. Thompson J.E., Phillips R.J., Erdjument-Bromage H., Tempst P., Ghosh S. IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell. 80:1995;573-582.
39. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 412:2001;346-351.
40. Wu M.X., Ao Z., Prasad K.V., Wu R., Schlossman S.F. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science. 281:1998;998-1001.
41. Yang J., Lin Y., Guo Z., Cheng J., Huang J., Deng L., Liao W., Chen Z., Liu Z., Su B. The essential role of MEKK3 in TNF-induced NF-κB activation. Nat. Immunol. 2:2001;620-624.
42. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 91:1997;243-252.
43. Zandi E., Chen Y., Karin M. Direct phosphorylation of IκB by IKKα and IKKβ discrimination between free and NF-κB-bound substrate Science. 281:1998;1360-1363.
44. Zhao Q., Lee F.S. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase-β J. Biol. Chem. 274:1999;8355-8358.